• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期接近正常血糖水平对糖尿病肾病进展的影响。

Effect of long-term near-normoglycemia on the progression of diabetic nephropathy.

作者信息

Ciavarella A, Vannini P, Flammini M, Bacci L, Forlani G, Borgnino L C

出版信息

Diabete Metab. 1985 Feb;11(1):3-8.

PMID:3884404
Abstract

The effect of prolonged restoration of near-normoglycemia on the progression of diabetic nephropathy was evaluated in a controlled study in which 10 insulin-dependent (type 1) diabetic patients with clinical proteinuria were randomized to continue with conventional insulin treatment (CIT) or to undertake more intensive diabetic therapy using continuous subcutaneous insulin infusion (CSII). The patients, mean age 33 +/- 8 yr, mean duration of diabetes 15 +/- 4 yr, were studied before and during 12 months of either CIT or CSII therapy. Glycemic control was assessed by means of mean blood glucose (MBG) +/- Standard deviation (SD), urinary glucose excretion and glycosylated hemoglobin, while renal function was assessed by albumin, IgG and beta-2-microglobulin urinary excretion rates, serum creatinine and creatinine clearance. Blood glucose level, urinary glucose excretion and glycosylated hemoglobin fell significantly in the CSII group, while no differences were found in the CIT group after the 12 months observation period. Both groups showed a deterioration in all indices of renal function, as illustrated by an increase of protein excretion rates and of serum creatinine, and by a decline in creatinine clearance. Comparison of the rate of increase of urinary albumin and IgG excretion and of serum creatinine and of the rate of fall in creatinine clearance between CIT and CSII groups demonstrated that the rate of progression of diabetic nephropathy may be slowed by correction of hyperglycemia. Our study, with due reservations because of the small number of examined patients and differences in kidney function at the beginning of the trial shows that intensive diabetic care may play a role in the proteinuric stage of diabetes in slowing further destruction of residual glomerular structure and in delaying end stage renal failure.

摘要

在一项对照研究中,评估了长期恢复近正常血糖水平对糖尿病肾病进展的影响。该研究将10名患有临床蛋白尿的胰岛素依赖型(1型)糖尿病患者随机分为两组,一组继续接受常规胰岛素治疗(CIT),另一组采用持续皮下胰岛素输注(CSII)进行更强化的糖尿病治疗。这些患者的平均年龄为33±8岁,糖尿病平均病程为15±4年,在CIT或CSII治疗的12个月之前及期间接受研究。通过平均血糖(MBG)±标准差(SD)、尿糖排泄和糖化血红蛋白评估血糖控制情况,同时通过白蛋白、IgG和β2-微球蛋白的尿排泄率、血清肌酐和肌酐清除率评估肾功能。在12个月的观察期后,CSII组的血糖水平、尿糖排泄和糖化血红蛋白显著下降,而CIT组未发现差异。两组的所有肾功能指标均出现恶化,表现为蛋白质排泄率和血清肌酐升高,以及肌酐清除率下降。比较CIT组和CSII组之间尿白蛋白和IgG排泄增加率、血清肌酐增加率以及肌酐清除率下降率,结果表明纠正高血糖可能会减缓糖尿病肾病的进展速度。由于本研究中受检患者数量较少且试验开始时肾功能存在差异,故需有所保留,但研究表明强化糖尿病治疗在糖尿病蛋白尿阶段可能发挥作用,可减缓残余肾小球结构的进一步破坏,并延缓终末期肾衰竭的发生。

相似文献

1
Effect of long-term near-normoglycemia on the progression of diabetic nephropathy.长期接近正常血糖水平对糖尿病肾病进展的影响。
Diabete Metab. 1985 Feb;11(1):3-8.
2
Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria.1型(胰岛素依赖型)糖尿病患者有蛋白尿和无蛋白尿时肾小球滤过的大小和电荷选择性
Diabetologia. 1993 Mar;36(3):244-51. doi: 10.1007/BF00399958.
3
Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement.5年接近正常血糖水平对早期糖尿病视网膜病变进展及肾脏受累情况的影响。
Diabetes Res. 1990 Dec;15(4):185-90.
4
Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia.糖尿病中的蛋白尿:血糖自发及实验性变化的作用
Kidney Int. 1982 May;21(5):714-20. doi: 10.1038/ki.1982.87.
5
Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy.
Diabetes Res Clin Pract. 1993 Aug-Sep;21(2-3):115-22. doi: 10.1016/0168-8227(93)90058-d.
6
Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria.
Diabetes. 1985 Aug;34 Suppl 3:69-73. doi: 10.2337/diab.34.3.s69.
7
Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy.改善胰岛素依赖型糖尿病(IDDM)患者的血糖控制可延缓早期糖尿病肾病形态学变化的进展。
Diabetologia. 1994 May;37(5):483-90. doi: 10.1007/s001250050136.
8
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.血糖控制对胰岛素依赖型糖尿病患者尿白蛋白及β2微球蛋白排泄的影响
N Engl J Med. 1979 Mar 22;300(12):638-41. doi: 10.1056/NEJM197903223001202.
9
Diurnal variation in urinary protein excretion in diabetic nephropathy.
Nephrol Dial Transplant. 1991;6(4):238-43. doi: 10.1093/ndt/6.4.238.
10
Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control.糖尿病患者间歇性临床蛋白尿与肾功能:演变及血糖控制的影响
Br Med J (Clin Res Ed). 1986 Jan 11;292(6513):83-6. doi: 10.1136/bmj.292.6513.83.

引用本文的文献

1
The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)-A Narrative Review.钠-葡萄糖共转运蛋白 2 抑制剂(SGLT2i)的肾保护机制:一篇叙述性综述。
Int J Mol Sci. 2024 Jun 27;25(13):7057. doi: 10.3390/ijms25137057.
2
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.糖尿病肾病的病理生理机制及潜在生物标志物。
Diabetes Metab J. 2022 Mar;46(2):181-197. doi: 10.4093/dmj.2021.0329. Epub 2022 Mar 24.
3
Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney.钠-葡萄糖协同转运蛋白2抑制剂与肾脏
Diabetes Spectr. 2021 Aug;34(3):225-234. doi: 10.2337/ds20-0071. Epub 2021 Aug 18.
4
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.糖尿病肾病的病理生理学:SGLT2 抑制剂的影响。
Nat Rev Nephrol. 2021 May;17(5):319-334. doi: 10.1038/s41581-021-00393-8. Epub 2021 Feb 5.
5
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.用于治疗糖尿病和慢性肾脏病患者的胰岛素及降糖药物。
Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2.
6
Glucose targets for preventing diabetic kidney disease and its progression.预防糖尿病肾病及其进展的血糖目标。
Cochrane Database Syst Rev. 2017 Jun 8;6(6):CD010137. doi: 10.1002/14651858.CD010137.pub2.
7
Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.1型糖尿病合并蛋白尿患者血糖控制改善与终末期肾病风险
J Am Soc Nephrol. 2014 Dec;25(12):2916-25. doi: 10.1681/ASN.2013091002. Epub 2014 Jun 5.
8
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.1型糖尿病强化血糖控制与传统血糖控制的比较
Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2.
9
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.糖尿病患者皮下胰岛素持续输注与多次每日胰岛素注射的比较:系统评价与荟萃分析
Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Epub 2008 Mar 20.
10
Diabetic control and microvascular complications: the near-normoglycaemic experience.糖尿病控制与微血管并发症:近正常血糖水平的经验
Diabetologia. 1986 Oct;29(10):677-84. doi: 10.1007/BF00870275.